RedHill Biopharma
- Biotech or pharma, therapeutic R&D
RedHill Biopharma Ltd. (Nasdaq: RDHL) is a specialty biopharmaceutical company primarily focused on the U.S development and commercialization of drugs for gastrointestinal diseases, infectious diseases, oncology, and medical countermeasures. RedHill has a robust development pipeline with multiple R&D programs and established commercial operations in the U.S., where it markets the gastrointestinal drug Talicia® for the treatment of Helicobacter pylori (H. pylori) infection in adults.
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
){kind=logo}